Exclude secondary organic causes of obesity by diagnosis prior to therapy. Not recommended to be co-administered w/ drug products for wt loss. Valvular heart disease, primary pulmonary HTN, mild HTN, diabetes, established CAD, epilepsy, patients receiving psychotrophic drugs or antihypertensives. May impair the ability to drive or operate machinery. Wt loss should be gradual & controlled.